🔗 Permalink

Inventor profile of:

Peter L. Collins

City:

Silver Spring, Maryland

Country:

United States

Published Applications:

Last publication date:

2026-04-02

Top Assignees for applications by Peter L. Collins

The entities that hold a legal rights for patent applications filed by inventor Collins Peter L.:

The United States of America, as represented by the Secretary, Department of Health and Human Services 10 Bethesda, MD United States
The United States of America as Represented by the Department of Health and Human Services 5 Washington, DC United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 4 Washington, DC United States
The USA, as represented by the Secretary, Department of Health and Human Services 4 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Servic 3 Bethesda, MD United States
The Research Foundation for the State University of New York 3 Albany, NY United States
The United States of America,as represented by the Secretary,Department of Health and Human Services 2 Bethesda, MD United States
Codagenix, Inc. 2 Stony Brook, NY United States
The United States of America, as represented by the Secretary, Dept. of Health and Human Services 2 Bethesda, MD United States
The United States of America, As Represented by the Secretary, Department of Health & Human Services 1 Bethesda, MD United States
RUSH UNIVERSITY MEDICAL CENTER 1 Chicago, IL United States
The United States of America, as Represented by the Secretary, Dept. of Health and Human Services 1 Washington, DC United States
The United States of America, as represented by the Secretary, Department of Health and Human 1 Bethesda, MD United States
National Institutes of Health, Office of Technology Transfer 1 Rockville, MD United States
University of Maryland, College Park 1 College Park, MD United States
The Government of the United States of America Represented by the Secretary 1 Rockville, MD United States
The Govt. of the U.S.A, Department of Health and Human Services National Institutes of Health 1 Rockville, MD United States
The USA, Secretary, DHHS 1 Bethesda, MD United States
The United States of America, as Represented by the Secretary, Department of Health & Human Services 1 Bethesda, MD United States
The Government of the US, Represented by the Secretary, Dept. of Health and Human Services 1 Rockville, MD United States
The USA, as represented by the Secretary, Dept. of Health and Human Services 1 Bethesda, MD United States
THE UNITED STATES OF AMERICA, AS REPRESENTED BY HE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SER 1 Bethesda, MD United States
National Institutes of Health 1 Rockville, MD United States
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF 1 Bethesda, MD United States
The United States of America, represented by the Secretary, Department of Health and Human Services 1 Washington, DC United States
Codagenix Inc. 1 Farmingdale, NY United States

Recent patent applications by Collins Peter L.

Peter L. Collins from Silver Spring, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-02

US20260091105A1

Human necessities

METHOD OF VACCINATION WITH AN ATTENUATED RSV VACCINE FORMULATION

#2 | 2024-12-19

US20240417699A1

Chemistry; metallurgy

ATTENUATION OF HUMAN RESPIRATORY SYNCYTIAL VIRUS BY GENOME SCALE CODON-PAIR DEOPTIMIZATION

#3 | 2024-12-19

US20240417431A1

Chemistry; metallurgy

VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES

#4 | 2024-11-28

US20240392317A1

Chemistry; metallurgy

CHIMERIC VECTORS

#5 | 2024-07-11

US20240226118A1

Human necessities

USE OF OUABAIN ANTAGONISTS TO INHIBIT VIRAL INFECTION

#6 | 2024-06-20

US20240197861A1

Human necessities

RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING SARS-COV-2 SPIKE PROTEIN AND ITS USE

#7 | 2023-06-29

US20230201327A1

Human necessities

RSV VACCINE BEARING ONE OR MORE P GENE MUTATIONS

#8 | 2022-10-27

US20220340619A1

Chemistry; metallurgy

Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes

#9 | 2022-10-13

US20220325252A1

Chemistry; metallurgy

Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

#10 | 2022-08-11

US20220249518A1

Human necessities

USE OF OUABAIN ANTAGONISTS TO INHIBIT VIRAL INFECTION

#11 | 2022-07-21

US20220226458A1

Human necessities

Recombinant chimeric bovine/human parainfluenza virus 3 expressing rsv g and its use

#12 | 2021-10-28

US20210330782A1

Human necessities

GENETICALLY STABLE LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE AND ITS PRODUCTION

#13 | 2021-06-24

US20210189425A1

Chemistry; metallurgy

Chimeric vectors

#14 | 2021-06-24

US20210188920A1

Chemistry; metallurgy

Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes

#15 | 2021-06-17

US20210177960A1

Human necessities

Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts

#16 | 2021-05-20

US20210145958A1

Human necessities

Recombinant chimeric bovine/human parainfluenza virus 3 expressing RSV G and its use

#17 | 2020-09-10

US20200283740A1

Chemistry; metallurgy

Recombinant respiratory syncytial virus strains with mutations in the M2-2 ORF providing a range of attenuation phenotypes

#18 | 2019-09-19

US20190282690A1

Human necessities

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

#19 | 2019-08-01

US20190233476A1

Chemistry; metallurgy

Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes

#20 | 2019-06-20

US20190184000A1

Human necessities

Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts

#21 | 2019-02-07

US20190040365A1

Chemistry; metallurgy

Recombinant respiratory syncytial virus stains with mutations in the M2-2 ORF providing a range of attenuation phenotypes

#22 | 2018-11-08

US20180318411A1

Human necessities

Method of vaccination with an attenuated RSV vaccine formulation

#23 | 2018-07-26

US20180208906A1

Chemistry; metallurgy

Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

#24 | 2017-07-06

US20170189520A1

Human necessities

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

#25 | 2015-12-24

US20150368622A1

Chemistry; metallurgy

Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

#26 | 2015-04-30

US20150118732A1

Chemistry; metallurgy

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

#27 | 2013-02-28

US20130052718A1

Chemistry; metallurgy

Attenuated human parainfluenza virus, methods and uses thereof

#28 | 2011-09-08

US20110217266A1

Human necessities

Genomic sequence of avian paramyxovirus type 2 and uses thereof

#29 | 2011-08-04

US20110189232A1

Chemistry; metallurgy

RECOMBINANT HUMAN PARAINFLUENZA TYPE 1 VIRUSES (HPIV1s) CONTAINING MUTATIONS IN OR DELETION OF THE C PROTEIN ARE ATTENUATED IN AFRICAN GREEN MONKEYS AND IN CILIATED HUMAN AIRWAY EPITHELIAL CELLS AND ARE POTENTIAL VACCINE CANDIDATES FOR HPIV1

#30 | 2010-12-30

US20100330120A1

Chemistry; metallurgy

HUMAN PARAINFLUENZA VIRUSES HAVING SEPARATED P AND C GENES

#31 | 2007-08-09

US20070184069A1

Chemistry; metallurgy

Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

#32 | 2007-03-20

US9733692

Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens

#33 | 2006-12-07

US20060275774A1

Chemistry; metallurgy

Negative strand RNA virus replicon

#34 | 2006-03-16

US20060057158A1

Chemistry; metallurgy

Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

#35 | 2006-02-02

US20060024797A1

Chemistry; metallurgy

Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes

#36 | 2006-01-26

US20060018927A1

Chemistry; metallurgy

Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes

#37 | 2005-07-21

US20050158338A1

Chemistry; metallurgy

Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions

InventorID:

114900 ⎘